PropertyValue
?:abstract
  • We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.
?:creator
?:journal
  • Subst_Abus
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment
?:type
?:who_covidence_id
  • #104139
  • #32314951
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/DB00864_hasdse_Carpal_tunnel_syndrome>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/DB00864_hasdse_Carpal_tunnel_syndrome>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all